Literature DB >> 109096

Studies on the specificity and clinical correlation of antiribosomal antibodies in systemic lupus erythematosus sera.

D Koffler, T E Miller, R G Lahita.   

Abstract

The specificity of antibodies reactive with cytoplasmic ribosomes detected in systemic lupus erythematosus (SLE) sera was studied by a radioimmunoassay procedure with 3H labeled HeLa cell polysomes. The antibodies were directed primarily against RNA or a ribosomal RNA-protein complex (rRNP). Anti-RNA antibodies exhibited comparable reactivity with ribosomal RNA, nuclear RNA, structural RNA, and a slightly lower degree of reactivity with low molecular weight RNA. Anti-rRNP antibodies may be detected by precipitation in agar gel and appear to require both the RNA and protein moieties of ribosomes for reactivity. SLE sera containing only anti-rRNP antibodies are limited to patients with active disease. Sera from patients with both active and inactive SLE contain either anti-RNA or a mixture of anti-RNA and anti-rRNP antibodies. The possible participation of anti-ribosomal antibodies in immune complex formation is discussed.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 109096     DOI: 10.1002/art.1780220505

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  10 in total

Review 1.  B-cell epitopes of RNA autoantigens.

Authors:  R M Hoet; W J van Venrooij
Journal:  Mol Biol Rep       Date:  1992-06       Impact factor: 2.316

Review 2.  Autoantibodies involved in neuropsychiatric manifestations associated with systemic lupus erythematosus: a systematic review.

Authors:  Savino Sciascia; Maria Laura Bertolaccini; Dario Roccatello; Munther A Khamashta; Giovanni Sanna
Journal:  J Neurol       Date:  2014-06-21       Impact factor: 4.849

3.  Interactions of antisera to different Chlamydia and Chlamydophila species with the ribosomal protein RPS27a correlate with impaired protein synthesis in a human choroid plexus papilloma cell line.

Authors:  Abdullah Almamy; Christian Schwerk; Horst Schroten; Hiroshi Ishikawa; Abdul Rahman Asif; Bernhard Reuss
Journal:  Immunol Res       Date:  2017-12       Impact factor: 2.829

4.  Analysis of antibodies to RNA in patients with systemic lupus erythematosus and other autoimmune rheumatic diseases.

Authors:  F Blanco; J Kalsi; D A Isenberg
Journal:  Clin Exp Immunol       Date:  1991-10       Impact factor: 4.330

5.  International multicenter evaluation of autoantibodies to ribosomal P proteins.

Authors:  Michael Mahler; Kai Kessenbrock; Magdalena Szmyrka; Yoshinari Takasaki; Ignacio Garcia-De La Torre; Yehuda Shoenfeld; Falk Hiepe; Chen Shun-le; Carlos A von Mühlen; Henning Locht; Peter Höpfl; Allan Wiik; Westley Reeves; Marvin J Fritzler
Journal:  Clin Vaccine Immunol       Date:  2006-01

6.  Anti-ribosomal ribonucleoprotein autoantibodies in systemic lupus erythematosus.

Authors:  P L Meroni; G de Bartolo; W Barcellini; P S Riboldi; R Basile; C Betterle; C Zanussi
Journal:  J Clin Immunol       Date:  1984-01       Impact factor: 8.317

7.  Autoantibody to ribosomes and systemic lupus erythematosus.

Authors:  J P Mathy; R Baum; B H Toh
Journal:  Clin Exp Immunol       Date:  1980-07       Impact factor: 4.330

8.  Limited reliability of the indirect immunofluorescence technique for the detection of anti-Rib-P antibodies.

Authors:  Michael Mahler; Jennifer T Ngo; Johannes Schulte-Pelkum; Tanja Luettich; Marvin J Fritzler
Journal:  Arthritis Res Ther       Date:  2008-11-11       Impact factor: 5.156

9.  Description and partial characterization of a nucleolar RNA-associated autoantigen defined by a human monoclonal antibody.

Authors:  N Chiorazzi; W H Reeves
Journal:  J Exp Med       Date:  1987-04-01       Impact factor: 14.307

10.  Lupus autoantibodies target ribosomal P proteins.

Authors:  K B Elkon; A P Parnassa; C L Foster
Journal:  J Exp Med       Date:  1985-08-01       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.